首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2018年 1期肝纤维化及肝硬化 => 肝脏肿瘤 =>经肝动脉化疗栓塞术联合门静脉内125I粒..
经肝动脉化疗栓塞术联合门静脉内125I粒子植入治疗原发性肝癌合并门静脉癌栓的效果观察
Clinical effect of transarterial chemoembolization combined with endovascular implantation of iodine-125 seeds in treatment of primary liver cancer complicated by portal vein tumor thrombus
文章发布日期:2017年12月09日  来源:  作者:王巧瑜,潘洁,周元敏  点击次数:615次  下载次数:130次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 探讨经肝动脉化疗栓塞术(TACE)联合门静脉内125I粒子植入技术治疗原发性肝癌合并门静脉癌栓(PVTT)患者的效果及对肝功能的影响。方法 回顾性分析2013年1月-2016年12月广州市第十二人民医院收治的96例原发性肝癌合并PVTT患者临床资料,其中52例患者采取TACE+门静脉腔内放射性125I粒子植入治疗(联合组),44例患者仅采取了TACE治疗(对照组),对比两组患者肿瘤病灶、PVTT的治疗效果,以及治疗前后相关实验室指标的变化。计量资料两组间比较采用t检验;计数资料组间比较采用χ2检验。结果 联合组的肿瘤病灶缓解率(59.62% vs 38.64%)、PVTT缓解率(80.77% vs 59.09%)高于对照组,差异均有统计学意义(χ2值分别为4.196、5.421,P值分别为0.041、0.020)。术后8周,联合组患者的血清AFP、门静脉主干直径、PLT测定值均低于对照组,血清ALT、AST、TBil水平均高于对照组,差异均有统计学意义(t值分别为3.891、3.291、2.330、3.729、3.582、4.126,P值均<0.05)。两组患者术后8周的血清AST、ALT、TBil水平较同组术前均显著升高(P值均<0.05),外周血PLT、AFP、门静脉主干直径较同组术前显著降低(P值均<0.05)。结论 TACE联合门静脉内125I粒子植入技术对原发性肝癌合并PVTT患者的治疗效果优于单纯TACE,但治疗过程中应注意其引起的肝功能损伤。
【Abstract】:Objective To investigate the clinical effect of transarterial chemoembolization (TACE) combined with endovascular implantation of iodine-125 seeds in the treatment of primary liver cancer complicated by portal vein tumor thrombus (PVTT) and its influence on liver function. Methods A retrospective analysis was performed for the clinical data of 96 patients with primary liver cancer complicated by PVTT who were admitted to Guangzhou No.12 People′s Hospital from January 2013 to December 2016. Among these patients, 52 were treated with TACE combined with endovascular implantation of iodine-125 seeds in the portal vein (combination group) and 44 were treated with TACE alone (control group). The two groups were compared in terms of the outcome of tumor lesions and PVTT and the changes in related laboratory markers after treatment. The t-test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. Results Compared with the control group, the combination group had significantly higher remission rates of tumor lesions (59.62% vs 38.64%, χ2=4.196, P=0.041) and PVTT (80.77% vs 59.09%, χ2=5.421, P=0.020). At 8 weeks after surgery, the combination group had significantly lower serum alpha-fetoprotein(AFP), diameter of the main portal vein, and platelet count(PLT) and significantly higher serum levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST), and total bilirubin(TBil) than the control group (t=3.891, 3.291, 2.330, 3.729, 3.582, and 4.126, all P<0.05); both groups showed significant increases in serum levels of ALT, AST, and TBil (all P<0.05) and significant reductions in PLT, serum AFP and diameter of the main portal vein (all P<0.05). Conclusion TACE combined with endovascular implantation of iodine-125 seeds in the portal vein has a better clinical effect than TACE alone in the treatment of primary liver cancer complicated by PVTT, but more attention should be paid to liver impairment during treatment.
【关键字】:肝肿瘤;化学栓塞,治疗性;碘放射性同位素;治疗结果
【Key words】:liver neoplasms; chemoembolization, therapeutic; iodine radioisotopes; treatment outcome
【引证本文】:WANG QY, PAN J, ZHOU YM. Clinical effect of transarterial chemoembolization combined with endovascular implantation of iodine-125 seeds in treatment of primary liver cancer complicated by portal vein tumor thrombus[J]. J Clin Hepatol, 2018, 34(1): 137-141. (in Chinese)
王巧瑜, 潘洁, 周元敏. 经肝动脉化疗栓塞术联合门静脉内125I粒子植入治疗原发性肝癌合并门静脉癌栓的效果观察[J]. 临床肝胆病杂志, 2018, 34(1): 137-141.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号